Cephalon data

Cephalon Inc. Cephalon Inc. said that in a Phase I trial of its Myotrophin insulin-like growth factor-1 in 10 patients with amyotrophic lateral sclerosis, levels of IGF-1 rose to 400 nanograms/ml fr...